Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Rectal Neoplasms × penpulimab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Squamous Cell Carcinoma of Head and Neck 2 Stomach Neoplasms 1 Rectal Neoplasms 1 Pancreatic Adenocarcinoma Metastatic 1 Osteosarcoma 1 Gastrointestinal Neoplasms 1 Gastrointestinal Diseases 1 Digestive System Diseases 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 Carcinoma 1 Advanced Solid Tumor 1 Advanced Pancreatic Cancer 1

Interventions

Capecitabine 25 Oxaliplatin 23 Radiotherapy 16 Fluorouracil 15 Surgical Procedures, Operative 11 Drug Therapy 10 Chemoradiotherapy 9 Bevacizumab 9 Leucovorin 8 Consolidation Chemotherapy 7 Radiation 6 sintilimab 5 XELOX 5 Specimen Handling 5 Irinotecan 5 Folfox protocol 5 spartalizumab 4 Radiotherapy, Intensity-Modulated 4 Neoadjuvant Therapy 4 Cetuximab 4 trifluridine tipiracil drug combination 3 pembrolizumab 3 irinotecan sucrosofate 3 fludarabine 3 dehydroftorafur 3 Proctectomy 3 Nivolumab 3 Mastectomy, Segmental 3 Magnetic Resonance Spectroscopy 3 Endoscopy 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05576480 2025-08-28

SPARC

Ruijin Hospital

Phase 2 Recruiting

Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡